Skip to main content
MedPathMedPath Home
Clinical Trials/NCT02515500
NCT02515500
Completed
Not Applicable

Cigarette Reduction Using the Quitbit Digital Lighter and Mobile Application for Smoking Cessation: a Randomized Controlled Trial

University of California, San Francisco1 site in 1 country124 target enrollmentJune 2016
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSmoking Cessation

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Smoking Cessation
Sponsor
University of California, San Francisco
Enrollment
124
Locations
1
Primary Endpoint
Saliva cotinine level
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The study is designed to evaluate the efficacy of a cigarette reduction intervention using a novel device called the Quitbit, a digital lighter paired with a smartphone mobile application, to enhance self-regulatory techniques for reducing cigarettes smoked per day toward cessation.

Registry
clinicaltrials.gov
Start Date
June 2016
End Date
June 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •18 years of age
  • •cigarette smoker
  • •wanting to quit in the next 30 days
  • •preference to quit gradually (vs. abruptly) or having no preference
  • •access to an iPhone (iOS only)
  • •completion of a run-in period

Exclusion Criteria

  • •no major change in number of cigarettes per day in the past month (+/- 20%)
  • •no major health diagnoses that could impact study attrition

Outcomes

Primary Outcomes

Saliva cotinine level

Time Frame: 6 Months

Study Sites (1)

Loading locations...

Similar Trials

Active, not recruiting
Not Applicable
Digitally Enhanced Smoking Cessation for High Risk SmokersSmokingSmoking CessationLung Cancer ScreeningSmoking, TobaccoSmoking Behaviors
NCT04691297Dana-Farber Cancer Institute153
Withdrawn
Not Applicable
Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical VerificationNicotine AddictionDrug AddictionDrug DependenceSubstance Use DisorderTobacco Dependence
NCT05440721Click Therapeutics, Inc.
Withdrawn
Not Applicable
Tobacco Retraining of Automatic Approach to Treat Individuals With Tobacco Dependence and Severe Concurrent Disorders.Tobacco Retraining of Automatic ApproachPlacebo Task
NCT01902199University of British Columbia
Completed
Phase 2
Innovative Interventions for Smoking CessationTobacco Use Disorder
NCT01050569University of Minnesota235
Completed
Not Applicable
E-cigarettes to Promote Smoking Reduction Among Individuals With SchizophreniaTobacco Smoking
NCT02918630The University of Texas Health Science Center, Houston7